医渡科技助力重医附二院推出乙肝治愈AI助手

Core Viewpoint - The launch of the world's first "Hepatitis B Cure AI Assistant" by Yidu Technology in collaboration with Chongqing Medical University Second Affiliated Hospital aims to provide a comprehensive closed-loop service for Hepatitis B management, addressing issues such as fragmented information and inefficient clinical research recruitment [1][2]. Group 1: AI Assistant Features - The AI assistant is built on a medical domain-specific large model and offers a one-stop service covering screening, diagnosis, treatment, follow-up, and research [1]. - It operates on a smart management system that integrates clinical pathways and utilizes retrieval-augmented generation (RAG) technology to create a digital support system throughout the disease management process [1][2]. - The assistant acts as a "personal health manager," enabling continuous intelligent services for patients, including follow-ups, personalized education, health consultations, and appointment reminders [1]. Group 2: Clinical Collaboration and Data Integration - The AI assistant enhances clinical collaboration by covering the entire process from high-risk population screening to long-term follow-up and rehabilitation guidance, while also bridging the gap between research and clinical data [2]. - The collaboration between Yidu Technology and Chongqing Medical University has led to the establishment of a high-quality "Hepatitis B Specialty Database," which supports the AI assistant's capabilities [2]. - The assistant's effectiveness has been validated in clinical settings, demonstrating its ability to provide personalized risk assessments and decision support based on complex medical logic [2]. Group 3: Future Developments - The AI assistant is currently undergoing testing on both mobile and computer platforms, with plans for patients to access pre-consultation services and expert recommendations through a user-friendly interface [3]. - Yidu Technology plans to explore innovative services such as specialized large models and digital avatars for doctors, expanding the boundaries of intelligent management in the field of liver disease [3].